Podcasts about Clinical pharmacy

Join Drs. Neil Skolnik and Sara Wettergreen in this episode as they discuss the importance of emotional wellbeing in overall health. They will explore the connection between mental health and diabetes, focusing on how managing a chronic condition can impact the emotional lives of people living with diabetes and their families. Special guest Dr. Kelsey Brzezinski will also join the conversation.   Please note that this episode includes discussions of sensitive topics, we encourage you to listen with care and understand that the American Diabetes Association® is not an organization that specializes in mental health and only seeks to bring awareness to factors that coincide with a diabetes diagnosis. If you are experiencing challenges seek the support of a licensed medical or mental health professional. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Kelsey Brzezinski, PhD, Pediatric Psychologist at Lurie Children's Hospital of Chicago, Assistant Professor of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine, Chicago, IL   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: If you or a loved one are experiencing a mental health crisis, please call the 988 Suicide & Crisis Lifeline. SAMHSA mental health help line, which is a no-cost, confidential, 24/7, 365-day-a-year treatment referral and information service available at 1-800-662-HELP (4357). Check out the American Diabetes Association®'s newly updated Mental Health Provider Directory to find to find therapists who specialize in supporting people living with diabetes near you.  

Hospitals today face rising drug costs, workforce shortages, supply chain disruptions and tightening reimbursement, making financial sustainability increasingly difficult to achieve. In this episode of Healthcare Insider, Cardinal Health's Mike Brown, R.Ph, vice president of managed services, and Michelle Dalton, PharmD, regional director of account management and operations, discuss how a strategic approach to pharmacy management can help hospitals of all sizes reduce costs, optimize operations and unlock new revenue streams. They also share how one Southeastern health system kept $3 million in clinical savings in one year by transforming pharmacy operations. Listen to learn how your organization can tap into the pharmacy's full potential to drive financial resilience and growth across your system.

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they share tips to increase movement in honor of April being Move More Month. Since we're all about movement and exercise, we're excited to welcome special guests Adrienne Edge and David Rachal III from the American Diabetes Association®'s (ADA) Project Power program. They'll share how you can get involved and start moving to stay healthy, prevent, or better manage type 2 diabetes. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Adrienne Edge, Founder of ProFIT Family Wellness, Community Partner and Facilitator Trainer for the ADA's Project Power program   David Rachal III, Nationally Respected Leader in Medical Fitness, Wellness, and Entrepreneurial Empowerment, Community Partner and Facilitator Trainer for the ADA's Project Power program   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   To learn more about Project Power, be sure to check out: diabetes.org/ProjectPower.

Drs. Adrian Wong, Sandra Kane-Gill, and Alexandre Chan discuss their ACCP Committee work with associate editor, Dr. Alan Zillich. The committees' work resulted in two papers describing the current and future role of AI in clinical pharmacy practice, research, and scholarship. Read the full-text manuscripts: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70004 and https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70003.

On March 19. 2025, The American College of Clinical Pharmacy published, "A review of antibiotic safety in pregnancy- 2025 Update". In this episode, we will review some of the confusion surrounding aminoglycosides, sulfa, and nitrofurantoin in pregnancy. Its interesting how different professions view certain medications in pregnancy. Does ACOG say you can use Sulfa in the third trimester? Can you use nitrofurantoin in the first trimester? Listen in for details. (SHOUT OUT to our partner podcast, CLINICAL PEARLS LATINO, for the topic idea. GRACIAS AMIGOS)

Antimicrobial resistance has become one of healthcare's biggest challenges, and in the fight against AMR getting the right drug, the right dose, right indication and the right route is everything. In this episode, we're exploring the critical role clinical pharmacists play in antimicrobial stewardship (AMS). Join Nonks, the latest microbe messenger to take the mic, as she talks to seasoned clinical pharmacist Ama Annor.About our Guest: Ama Sakoa Annor, is a committed and proactive pharmacist who is trained in comprehensive pharmaceutical care for paediatric patients. She holds an MSc (Med) in Clinical Pharmacy and a DPharm Candidate with six publications.She is currently working at Dr George Mukhari Academic Hospital as a ward pharmacist, stationed in the paediatric medical and surgical departments. She is a member of the hospital's Pharmacy and Therapeutics, AMS, ADR Committee and other sub-committees.She is also affiliated as a mentor with the Clinical Pharmacy Division of the School of Pharmacy of the Sefako Makgatho Health Sciences University. She has a passion for rational antimicrobial use and is privileged to be one of the mentees in the Ohio State University/Nationwide Children's Hospital - South Africa Train-the-Trainer program in the Neonatal Antimicrobial Stewardship Program in 2019. Two of the end products are the recent publications: “Prospective antimicrobial stewardship interventions by multidisciplinary teams to reduce neonatal antibiotic use in South Africa: the Neonatal Antimicrobial Stewardship (NeoAMS) study”. International Journal of Infectious Diseases 2024-06 | Journal article. https://doi.org/10.1016/j.ijid.2024.107158“Defining and responding to the contextual drivers for implementation of antimicrobial stewardship in 14 neonatal units in South Africa”; JAC-Antimicrobial Resistance 2025 Vol. 7 Issue 1 https://doi.org/10.1093/jacamr/dlae222Facebook: Ama Sakoa AnnorLinkedin_ama_sakoa-annorX: @ama_sakoa_annorInstagram: amasakoaAlso listen to this: Episode 6: A is for antimicrobial stewardshipWE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us:

Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the differences between FDA-approved medications and compounded and counterfeit medications, alongside special guests Dr. Susan Kuchera and Lisa Kessler. They will explore the factors that might influence the decision to use compounded treatments, the risks associated with these treatments, and one of our guests will share their personal experience with obesity treatment. This episode of Diabetes Day by Day is supported by Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan Kuchera, MD, Clinical Assistant Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University and Program Director of the Family Medicine Residency at Jefferson Health Abington   Lisa Kessler, MS, CCC-SLP, Infant-toddler Home-based Pediatric Speech-Language Pathologist   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! Learn more about the risks of buying medications online at the BeSafeRx website, the Food and Drug Administration's source for online pharmacy information. Read the American Diabetes Association®'s statement on compounded medications. 

Hospital clinical pharmacies play a key role in ensuring patients are taking medications effectively and supporting other providers who are managing their care. Mark Riggle, the assistant chief pharmacy officer at UC Davis Health, explains how 340B helps make this direct care and ancillary support possible.Clinical pharmacies are a bridge between providers and patientsRiggle says clinical pharmacy teams serve as drug experts that can help teach patients about potential side effects and how to take their medications properly. But these teams also can take the lead on supporting other providers on refills, prior authorizations, financial assistance, and more. That allows the other providers to focus less on those processes and more on providing medical care to the patients. In-house pharmacies can improve patient care and generate revenueUsing an in-house clinical pharmacy has benefits for both patients and the hospital. Riggle notes that keeping prescriptions and pharmacy support in-house can enable hospitals to keep better track of patients' health and identify if there are issues or questions with certain medications. At the same time, it generates revenue and 340B savings that support even more hospital services and improve patient health outcomes even more.Ramping up clinical pharmacy services and overcoming barriers can take timeRiggle says expanding clinical pharmacy initiatives at UC Davis Health has come with some challenges. It took years to roll out a refill program for all the providers who needed that support, and achieving success with a prior authorization program involved an evaluation of workflows to improve efficiency. But he noted that hospital pharmacists can present a value proposition to their leaders for how investing in 340B-supported clinical pharmacy services can be worth it to improve care quality and provider satisfaction.ResourcesFederal Judge Allows 340B Health, Member Hospitals To Intervene in Rebate Lawsuits

Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Over the Counter to discuss The Cut Hypertension Program, which operates in barbershops across the Bay Area in California. Zhou is the program's Lead Pharmacist and she is also an Associate Professor in the Department of Clinical Pharmacy at the University of California, San Francisco.

In this episode of the JACCP Podcast, hosts Robbie Parker and Stuart T. Haines discuss the impact of pharmacogenomics on formulary decision-making with Dr. Jacob Brown and Dr. Larisa Cavallari. The conversation highlights how genetic testing should influence a Pharmacy & Therapeutics (P&T) committee's work to optimize medication safety and effectiveness. The guests discuss the variability in pharmacogenomic adoption across institutions, barriers such as clinician education, cost, and reimbursement challenges, and the importance of physician-pharmacist collaboration. They also described gene-drug pairs where the evidence is compelling, like clopidogrel, fluoropyrimidines and codeine, demonstrating the value of pharmacogenetic-guided prescribing. Finally, they offer guidance for smaller institutions looking to implement pharmacogenomic strategies, emphasizing a stepwise approach and leveraging available resources. Read The impact of pharmacogenomics on a pharmacy and therapeutic committee's formulary system management: An opinion of the pharmacokinetics/pharmacodynamics/pharmacogenomics practice and Research Network for the American College of Clinical Pharmacy in JACCP.

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they dive into the world of mobile health technology and how it's shaping diabetes management. With so many apps for tracking blood glucose (blood sugar), counting carbs, and logging fitness activities, it can be tough to find the right one. In this episode, we welcome Susan Weiner, MS, RDN, CDCES, FADCES, a nutrition, health, and diabetes expert with knowledge of diabetes-related apps, and Bridget Wood, RD, LD, CDCES, who has lived with type 1 diabetes for over 15 years and has firsthand experience with apps that can assist with diabetes management. Our guests will share valuable insights on how apps can support people living with diabetes and why using them can be beneficial. This episode isn't sponsored, and we're not endorsing any specific app—just sharing examples of ones that have helped others. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan Weiner, MS, RDN, CDCES, FADCES — Columnist at Endocrine Today, Owner of Susan Weiner Nutrition, PLLC, and Nutrition Communicator and Media Consultant, New York City Metropolitan Area Bridget Wood, RD, LD, CDCES — Owner and Clinical Director of Bridget Wood Wellness, LLC, Reno, NV Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! For additional resources, be sure to check out: FDA Alert DiabetesWise ADCES Danatech Apps and Platforms Phone apps referenced: Glucose Blood Sugar Tracker Dario Health Livongo by Teladoc Health mySugr Dexcom G7 Tidepool OMRON (for blood pressure)

Hennepin EMS in Minnesota is breaking new ground in prehospital care with the introduction of a clinical pharmacist consulting role, designed to tackle complex challenges and foster collaboration between paramedics and pharmacists through hands-on support and cutting-edge research. The clinical pharmacist acts as a bridge between hospital and field operations, ensuring prehospital teams have the support they need to improve patient outcomes. A critical part of the pharmacist's responsibilities includes hands-on engagement. From participating in ambulance ride-alongs to hosting open-door consultations, this role prioritizes practical and actionable solutions. At the heart of this initiative is Holly Drone, PharmD, Hennepin EMS's clinical pharmacist. Not only has Holly been integral to placing this program into action, but she's also contributing to the field through her research. Her studies focus on essential topics such as Sodium Nitrate Overdose management, the initiation of Buprenorphine in prehospital settings, and the use of Oral Risperidone by EMS providers in the field. To learn more about this innovative role and hear directly about her experiences and research, check out her recent interview on the podcast “EMS Research with Professor Bram.” Holly provides unique insights into the evolving relationship between paramedics and pharmacists as well as the critical role clinical pharmacy plays in improving prehospital care.

High phosphorus (hyperphosphatemia) is a common complication caused by chronic kidney disease. Join us for this NKF Live to learn more about why this happens and how to successfully manage high phosphorus in CKD. During this program, you will hear a kidney doctor, a clinical pharmacist, and a person living with high phosphorus discuss important information to know about when managing high phosphorus.   Dr. Jay Wish is Professor of Clinical Medicine at Indiana University School of Medicine in Indianapolis and Chief Medical Officer for Outpatient Dialysis at Indiana University Health.  He is past president of the National Forum of ESRD Networks, served on the Board of Directors of the Renal Physicians Association and the American Association of Kidney Patients and was the recipient of the latter's Visionary Award in 2005. He has over 150 articles, reviews, and book chapters published, particularly in the areas of ESRD quality oversight/improvement, accountability, anemia management and vascular access. Dr. Katie Cardone is an associate professor at Albany College of Pharmacy and Health Sciences in Albany, NY. She is a clinical pharmacist with a clinical practice and research program focused on improving care in patients with kidney disease in outpatient nephrology and dialysis. She co-led the publication of pharmacy practice standards for pharmacists caring for people with kidney disease. She is a member of the Board of Pharmacy Specialties Ambulatory Care Pharmacy Council and is a fellow of the National Kidney Foundation, the American Society of Nephrology, and the American College of Clinical Pharmacy. Quenton Turner Gee has been on in-center hemodialysis for about 2 years. He was diagnosed with Stage 4 CKD in 2020. After a battle with COVID-19, it quickly progressed to end-stage kidney disease. Since starting on dialysis, he's been advocating for mental health and policies improving access to transplants and kidney innovations.   Additional Resources: Phosphate Lowering Agents High Phosphorus Information NKF Peers   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

A new year brings a new episode of Diabetes Day by Day! Join Drs. Neil Skolnik and Sara Wettergreen as they provide an overview of the ADA's Standards of Care in Diabetes—2025 and discuss their significance. They will also explore new updates you can bring up with your primary care provider during your next visit, including recommendations for using diabetes technology, weight management strategies, including medication therapy, and the latest insights on nutrition.  Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Equitable biomarker testing access, including pharmacogenomics testing, is critical for patients to experience optimal medication therapy outcomes. Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network (ACS CAN), educate listeners about ACS CAN's mission, how it executes on its mission, accomplishments, and future goals.  This episode is a must listen for anyone who wants the latest update on the American Cancer Society Cancer Action Network's work influencing state legislatures to pass legislation to expand coverage of biomarker testing, states who have already passed legislation and those with pending legislation, and to learn how they too can advocate.   After listening to this episode, listeners will be able to describe biomarker testing's importance in healthcare; describe how the American Cancer Society Cancer Action Network is championing biomarker testing coverage legislation; name states that have passed biomarker testing legislation and those with pending legislation; know how one can contribute to the efforts to increase biomarker testing coverage. Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor's degree in anthropology and global health from Williams College and a master's degree in social work from Boston College. She lives in San Diego with her husband and two children. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.  

Equitable biomarker testing access, including pharmacogenomics testing, is critical for patients to experience optimal medication therapy outcomes. Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network (ACS CAN), educate listeners about ACS CAN's mission, how it executes on its mission, accomplishments, and future goals.  This episode is a must listen for anyone who wants the latest update on the American Cancer Society Cancer Action Network's work influencing state legislatures to pass legislation to expand coverage of biomarker testing, states who have already passed legislation and those with pending legislation, and to learn how they too can advocate.   After listening to this episode, listeners will be able to describe biomarker testing's importance in healthcare; describe how the American Cancer Society Cancer Action Network is championing biomarker testing coverage legislation; name states that have passed biomarker testing legislation and those with pending legislation; know how one can contribute to the efforts to increase biomarker testing coverage. Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor's degree in anthropology and global health from Williams College and a master's degree in social work from Boston College. She lives in San Diego with her husband and two children. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.  

Interviews with Leaders in Clinical Pharmacy: Stuart T. Haines, Pharm.D., FCCP, FAPhA, FASHP, BCACP, BCPS, incoming JACCP Editor-in-Chief

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the topic of heart failure. They'll discuss steps you can take if you're living with diabetes to prevent it or detect it early, and receive timely treatment for better outcomes.  In this episode, we welcome guest Jim Januzzi, MD, Professor of Medicine at Harvard Medical School, Cardiologist at Massachusetts General Hospital, and Chief Scientific Officer at the Baim Institute for Clinical Research. Dr. Januzzi has published more than 900 manuscripts, edited 5 textbooks, and serves as a Deputy Editor at the Journal of the American College of Cardiology. He is a nationally recognized lecturer on the testing and treatment of heart failure. Dr. Januzzi will share valuable insights to help people living with diabetes, no matter where they are in their journey, as it relates to heart health and heart failure.  This episode of Diabetes Day by Day is supported by Roche. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Jim Januzzi, MD, Professor of Medicine at Harvard Medical School, Cardiologist at Massachusetts General Hospital, and Chief Scientific Officer at the Baim Institute for Clinical Research Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!  

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals. This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success.  After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists' contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.   Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah's molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master's degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University.  As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals. This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success.  After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists' contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.   Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah's molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master's degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University.  As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.

There's Nothing Like It is the theme for the ASHP Midyear Clinical Meeting 2024 and there's nothing like developing your clinical pharmacy leadership skills. Join experienced conference attendees and upcoming speakers presenting at the meeting to learn more about all Midyear has to offer!  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Tune in to the latest episode of Diabetes Day by Day! This time, Drs. Neil Skolnik and Sara Wettergreen zero in on nutrition in diabetes, offering practical tips and advice to help you thrive. Our special guests, Stacey Krawczyk, MS, RD, Director of Nutrition, and Toby Smithson, MS, RDN, CDCES, FAND, Senior Manager of Nutrition and Wellness—both from the American Diabetes Association®—share their insights and personal stories. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Stacey Krawczyk, MS, RD, Director of Nutrition at the American Diabetes Association® Toby Smithson, MS, RDN, CDCES, FAND, Senior Manager of Nutrition and Wellness at the American Diabetes Association® For additional resources, be sure to check out: The American Diabetes Association®'s Nutrition Tips The American Diabetes Association®'s Eating Patterns Healthy Plates Around the World Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

IN THIS EPISODE...Today's guest is Dr. Paul Peak, PharmD, the VP of Clinical Pharmacy at Sedgwick. With over a decade of expertise and nine years of prior pharmacy experience, Paul oversees Pharmacy Benefit Management partnerships and leads a clinical pharmacist team.In a dynamic landscape of pharmacy care, Dr. Paul Peak champions innovative strategies to manage employee wellness in workers' compensation. By aligning team vision with organizational goals and fostering a culture of open idea-sharing, he cultivates a collaborative environment that enhances professional growth while promoting a healthy work-life balance!------------Full show notes, guest bio, links to resources mentioned, and other compelling episodes can be found at http://LeadYourGamePodcast.com. (Click the magnifying icon at the top right and type “Dr. Paul”)Love the show? Subscribe, rate, review, and share! Learn more about us! https://shockinglydifferent.com/-------------WHAT TO LISTEN FOR:1. What are the current trends in pharmacy that impact the industry?2. How can teams align their vision with company goals effectively?3. How can organizations foster a culture of idea-sharing among teams?4. What key conversations are currently taking place in healthcare?5. How can individuals balance work and personal life in today's environment?6. What strategies can enhance leadership and team dynamics?7. How can leaders encourage open dialogue about personal and professional challenges?------------FEATURED TIMESTAMPS:[02:56] Paul's Personal Life[04:23] Paul and his team's Role at Sedgwick[08:56] Current Trends in Pharmacy[13:43] How to Align Team Vision with Company Goals[15:18] Signature Segment: Paul's entry into the LATTOYG Playbook: Leadership Approach and Team Dynamics[20:24] Strategies for Fostering Idea Sharing in Teams[22:07] Key Conversations in Healthcare[26:56] Balancing Work and Personal Life[29:58] Signature Segment: Paul's LATTOYG Tactic of Choice: Leading with Executive Presence[32:38] Connect with Paul------------ADDITIONAL RESOURCES FOR YOU:Overview: Our Signature Leadership Development Experience: http://bit.ly/DevelopYourGame

Join us for the latest episode of Diabetes Day by Day! This time, Dr. Neil Skolnik and Dr. Sara Wettergreen celebrate the start of Hispanic Heritage Month, exploring the role of nutrition and how cultural heritage can be embraced through food and community traditions. Our guests, Stacey Krawczyk, MS, RD, Director of Nutrition at the American Diabetes Association®, and Marina Chaparro, RD, CDCES, MPH, founder of Nutrichicos, a bilingual nutrition practice focusing on children and family nutrition, share their expertise and experiences. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Stacey Krawczyk, MS, RD, Director of Nutrition at the American Diabetes Association® Marina Chaparro, RD, CDCES, MPH, Founder of Nutrichicos For additional resources, be sure to check out: The American Diabetes Association®'s Nutrition Tips The American Diabetes Association®'s Eating Patterns Nutrichicos Healthy Plates Around the World Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

In this podcast, Dr. Leah Webster and Dr. Corey Wachter discuss the AJHP Descriptive Report, “The vital role of clinical pharmacy services within the hospital at home interdisciplinary team,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

New treatments and managing side effects are key challenges in kidney cancer care. In our latest episode of The PQI Podcast, we team up with the Kidney Cancer Association, Emily Wang, PharmD, BCOP, from MD Anderson, and Julia Stevens, PharmD, BCOP, from Beth Israel Deaconess, to share valuable insights into the newest advancements in kidney cancer therapies and practical strategies for managing side effects from TKI and IO treatments. Listen now to gain valuable knowledge that can transform your patient care approach.Learn more about the Kidney Cancer Association here. 

Check out the newest episode of Diabetes Day by Day! In this episode, Dr. Neil Skolnik and Dr. Sara Wettergreen delve into the challenges and triumphs of starting college with diabetes, discussing everything from dorm life to available resources. They are joined by guests who live with type 1 diabetes and will share their unique experiences: Saige Megyeri, a Pharmacy Student at the University of Colorado Skaggs School of Pharmacy, along with Peyton Skoczylas and Becca Burnett from The Diabetes Link. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Saige Megyeri, Pharmacy Student at the University of Colorado Skaggs School of Pharmacy Peyton Skoczylas, Senior Program Coordinator at The Diabetes Link Becca Burnett, Program Coordinator at The Diabetes Link For additional resources, be sure to check out: The American Diabetes Association®'s Safe at School College information: https://bit.ly/4cv3rqO The Diabetes Link's Off to College series: https://bit.ly/4dogPOJ The Diabetes Link's Online Resource Hub: https://bit.ly/3AnlGkG Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Vizient Pharmacy Vision Awards celebrate the values and achievements of our pharmacy members. The Excellence in Performance Improvement Award is given to an organization that achieves performance excellence and exceeds expectations in clinical, operations, specialty, retail, or 340B pharmacy. Corewell Health won award in 2023. Stephanie Field, VP, Finance – Pharmacy Business Services, and Margo Bowman, Senior Director of Clinical Pharmacy, are here from Corewell Health to discuss their award-winning program. I'm Gretchen Brummel your program host.   Guest speakers:  Stephanie Field, MBA Vice President Finance – Pharmacy Corewell Health   Margo Bowman, PharmD Senior Director of Clinical Pharmacy Corewell Health   Host:  Gretchen Brummel, PharmD, BCPS  VerifiedRx Host   Show Notes: [00:52-02:35] Background information Stephanie and Margo [02:36 - 03:46] Situation before the team started their work [03:47- 04:55] Coming up with a solution [04:56 - 06:05] The program [06:06 -09:20] Outcome improvements they have seen [09:21 - 11:14] How frontline staff responded to the program [11:15-12:18] Enhancing the program in the future.   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

Tune into the latest episode of Diabetes Day by Day! Hosts Dr. Neil Skolnik and Dr. Sara Wettergreen offer vital tips for traveling with diabetes and how to stay prepared for emergencies or natural disasters. Joining them are Dr. Steve Edelman from Taking Control of Your Diabetes (TCOYD) and Kelly O'Neal from the American Diabetes Association®. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Steve Edelman, MD, Founder and Director of Taking Control of Your Diabetes (TCOYD), Professor of Medicine at University of California San Diego-Veterans Affairs Healthcare System Kelly O'Neal, Director of Marketing, Programs and Partnerships, American Diabetes Association® Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Ever wondered what it takes to fight illness with radioactive materials? Buckle up, because Doc Talk is diving headfirst into the fascinating world of nuclear pharmacists! These aren't your average pill pushers. They're the frontline warriors, working with cutting-edge radiopharmaceuticals to diagnose and treat some of the toughest diseases.Join us as we chat with these rad (pun intended) experts Patrick Novak and Bryan Brittain. We'll unravel the mysteries of nuclear medicine, explore the latest advancements in targeted therapies, and discover the awe-inspiring ways nuclear pharmacists are changing the face of healthcare. Hosted on Acast. See acast.com/privacy for more information.

Tune in to the latest episode of Diabetes Day by Day! Hosts Dr. Neil Skolnik and Dr. Sara Wettergreen tackle the unique challenges faced by teens with type 1 diabetes and offer valuable insights on overcoming them. Joined by Nathan Bekelman, a teenager living with type 1 diabetes, who shares his inspiring personal journey. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Nathan Bekelman, Teenager living with type 1 diabetes Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Ever wondered who ensures your medications are safe and effective in the hospital? Meet the in-patient pharmacists: the behind-the-scenes heroes working tirelessly to optimize your treatment. Unlike their retail counterparts, they collaborate with doctors and nurses to personalize medication plans, navigate complex drug interactions, and catch potential side effects before they start. It's a world of fast-paced decisions and life-changing outcomes. Tune in and discover the unique role of in-patient pharmacists! Hosted on Acast. See acast.com/privacy for more information.

In a conversation with CancerNetwork®, Jagoda Misniakiewicz, PharmD, a clinical pharmacy specialist in the Clinical Pharmacy and Outcomes Sciences Department at Hollings Cancer Center of the Medical University of South Carolina, spoke about the use of fruquintinib (Fruzaqla) as a treatment option for those with metastatic colorectal cancer (CRC). The FDA previously approved fruquintinib as a treatment for those with metastatic CRC and prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy and anti-VEGF therapy in November 2023.1 Misniakiewicz detailed the agent's mechanism of action as a potent, orally available small molecule kinase inhibitor and its potential to inhibit blood vessel growth, thereby yielding vascular regression, normalization, and construction. Additionally, the clinical benefit of switching from intravenous therapy to this oral treatment appears to extend to any patient who has progressed on prior therapy, although she noted that there are currently no specific biomarkers or tumor characteristics that would make patients suitable candidates for fruquintinib. The discussion also focused on the efficacy and safety data supporting the clinical utility of fruquintinib in this patient population. Specifically, Misniakiewicz highlighted the “exciting” progression-free survival (PFS) findings from the phase 3 FRESCO-2 trial (NCT04322539), which may affirm fruquintinib as a “promising treatment option” for those with refractory disease.  According to previous findings from the FRESCO-2 trial published in Lancet Oncology, the median PFS was 3.7 months (95% CI, 3.5-3.8) with fruquintinib plus best supportive care vs 1.8 months (95% CI, 1.8-1.9) with placebo plus best supportive care (HR, 0.32; 95% CI, 0.27-0.39; P

In the latest episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen take a deep dive into strategies aimed at reducing the risk of progressing from prediabetes to type 2 diabetes. An astounding 1 in 3 American adults, nearly 98 million, are living with prediabetes. Alarmingly, 81% of them are unaware of their condition. This issue demands attention because, without intervention, many people living with prediabetes may progress to type 2 diabetes in as little as 5 years. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Ketamine has long been used as a procedural anesthesia, but according to some experts, it has the potential to treat pain conditions like depression, anxiety, post-traumatic stress disorder (PTSD) and more. In this podcast, Dr. Reema Hammoud, AVP, Clinical Pharmacy and Utilization Review and Dr. Teresa Bartlett, Managing Director, Managed Care weigh in on the risks and side effects of Ketamine, explore the research, share examples of medical versus recreational usage, and compare it to other medications.

In this insightful episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen delve into the newest approaches to discussing obesity treatments with your doctor and strategies for effectively planning this conversation. They are joined by Aaron Sutton, a behavioral health consultant, and Tamika Holland, who shares her personal journey with obesity. This is the third episode of a three-part series of Diabetes Day by Day that focuses on recognizing obesity as a chronic disease that requires treatment. Learn about strategies for tackling obesity, preparing for doctor's appointments, and overcoming the hurdles associated with initiating conversations about obesity. Discover more about medications and other innovative treatment options that provide renewed hope and much more. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of seven episodes: three episodes of Diabetes Day by Day, which will be tailored for people with overweight or obesity and their caregivers; and four episodes of its sister podcast, Diabetes Core Update, which will cover topics of interest for family physicians, primary care clinicians, and other health care professionals. The combined seven-episode program will be released between February and June 2024 and can be freely accessed at https://diabetesjournals.org/journals/pages/podcasts_obesity. Funding support for the “Focus on Obesity” series is jointly provided by Lilly and Novo Nordisk. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Aaron Sutton, LCSW, Behavioral Health Consultant, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Tamika Holland, Elementary Curriculum Specialist, Abington, PA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

In this highly informative episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen explore the latest in obesity management and treatment with a dual focus: lifestyle modifications and new medications. Recognizing obesity as a critical factor in overall health, Drs. Skolnik and Wettergreen are joined by Drs. Susan Fiddler and Wesley Nuffer to discuss the multifaceted approaches to obesity management. This is the second of a three-part series of Diabetes Day by Day that focuses on the critical issue of obesity, offering professional insights and advice to sustain weight management. Learn about lifestyle strategies for treating obesity, including eating habits, physical activity, and behavioral approaches, as well as groundbreaking medications offering new hope for those struggling with obesity. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of seven episodes: three episodes of Diabetes Day by Day, which will be tailored for people with overweight or obesity and their caregivers; and four episodes of its sister podcast, Diabetes Core Update, which will cover topics of interest for family physicians, primary care clinicians, and other health care professionals. The combined seven-episode program will be released between February and June 2024 and can be freely accessed at https://diabetesjournals.org/journals/pages/podcasts_obesity. Funding support for the “Focus on Obesity” series is jointly provided by Lilly and Novo Nordisk. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan K. Fiddler, MD, Associate Director, Family Medicine Residency    Program, Abington Jefferson Health, Abington, PA Wesley Nuffer, PharmD, BCPS, CDCES, BC-ADM, Professor, Assistant Director of Experiential Programs, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!    

This episode features Kersten Weber Tatarelis, PharmD, Vice President of Enterprise Clinical Pharmacy Operations at Advocate Health. Here, she provides key insights into her role, trends in pharmacy she is keeping an eye on, AI in the pharmacy space, and more.

In this enlightening episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen engage in a profound discussion on the topic of obesity, a pressing health issue that has seen a dramatic increase over the past 50 years. They are joined by Dr. Margarita McDonald, an obesity medical specialist, along with her patient, Tamika Holland, who shares her personal journey with obesity. This episode sheds light on the critical issue of obesity, offering both professional insights and personal experiences to foster a deeper understanding of the disease. By exploring the medical, psychological, and environmental aspects of obesity, Neil, Sara, Margarita, and Tamika provide a comprehensive overview that aims to inform, inspire, and encourage positive change in the way we view and care for obesity. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of seven episodes: three episodes of Diabetes Day by Day, which will be tailored for people with overweight or obesity and their caregivers; and four episodes of its sister podcast, Diabetes Core Update, which will cover topics of interest for family physicians, primary care clinicians, and other health care professionals. The combined seven-episode program will be released between February and June 2024 and can be freely accessed at https://diabetesjournals.org/journals/pages/podcasts_obesity. Funding support for the “Focus on Obesity” series is jointly provided by Lilly and Novo Nordisk. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Margarita McDonald, MD, Bariatrician and Medical Director, Bariatric Medicine Institute, Flourtown, PA Tamika Holland, Elementary Curriculum Specialist, Abington, PA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

2024 SCCM Congress: Tuesday Special Guests: Karen Berger, PharmD, FASHP, FCCM, BCCCP, BCPS Melanie Smith Condeni, PharmD, FCCM, BCPS, BCCCP Julie Farrar, PharmD, BCCCP Lama Nazer, PharmD, BCPS Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP Andy Webb, PharmD, BCCCP 03:05: Star Research Presentation: “Effect of Antipsychotics on Agitation in ICU Delirium: Secondary Analysis of a Randomized Trial” featuring Joanna Stollings 10:43: Star Research Presentations: “Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis (PRO-CAN)” & “Diagnostic and Prognostic Value of Procalcitonin in Critically Ill Cancer Patients with Sepsis” featuring Lama Nazer 25:32: Clinical Pharmacy and Pharmacology (CPP) Year in Review presenter and moderator roundtable discussion featuring Karen Berger, Melanie Smith Condeni, Julie Farrar, and Andy Webb 2024 SCCM Congress website: https://congress2024.sccm.org PharmacyToDose.com  @PharmacyToDose  PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Yun “Sherry” Wang is an Assistant Professor on the tenure track at Chapman University School of Pharmacy (CUSP). Her academic journey is built upon a foundation in Geospatial Science from Washington University in St. Louis, an exploration of Data Science at Monash University, and comprehensive Ph.D. training in Clinical Pharmacy. Since she arrived at Chapman in May 2021, she has established and led the "Patient Safety Lab," a research initiative driven by her profound interests in health service research and pharmacoepidemiology, with a special focus on substance users and chronic disease patients. The "Patient Safety Lab" is a collaborative effort that utilizes diverse real-world datasets to explore various projects, including "Opioid Prescribing and Overdose Deaths Before and During the COVID-19 Pandemic in California," "Utilization of Buprenorphine Treatments in California: A Real-World Assessment of X Waiver Holders and Prescribers," "Spatiotemporal Disparity Mapping of Buprenorphine Treatment," and "Treatment Adherence Disparities among Adolescents and Young Adults with Cancer." These multifaceted projects unite over ten dedicated faculty members and students, fostering collaboration beyond the boundaries of Chapman University. Dr. Wang's professional background encompasses a spectrum of disciplines, including machine learning, epidemiology, clinical pharmacy, health economics, and health service research across Asia, Australia, and the United States. Her contributions are evident through peer-reviewed publications in esteemed journals such as JAMA, Lancet, Clinical Infectious Disease, International Journal of Cardiology, Pharmacogenomics Journal, Drug and Alcohol Dependence, Pain Reports, and Neuroepidemiology. Her editorial role for the "Opioid Epidemic during the COVID-19 Pandemic" Special Issue of the journal Healthcare underscores her dedication to addressing the opioid crisis. Her research findings have garnered attention in ISPOR News Across Asia, Physician Weekly, and the COVID newsletter by the Washington State Department of Health. She received the American Association of Colleges of Pharmacy (AACP) New Investigator Award in 2022. Faculty profile: https://www.chapman.edu/our-faculty/sherry-yun-wang Google Scholar: https://scholar.google.com.au/citations?user=-RicqRIAAAAJ&hl=en

The Context of White Supremacy welcomes Dima Mazen Qato, PharmD, MPH, PhD. After many questions, Dr. Qato told Gus that she is classified as White although she was born in the area of the world known as Palestine and considers herself “arab,” and “middle eastern.” She also let us know she has blue eyes and is employed in a profession with few dark people. Currently serving as the Hygeia Centennial Chair and Associate Professor (with tenure) in the Titus Family Department of Clinical Pharmacy, Dr. Qato has also been appointed as a Senior Fellow with the USC Leonard D. Schaeffer Center for Health Policy and Economics. Gus found her research on Racism and Pharmacy access in the US while discussing the rash of pharmacy closures and the adverse impact on black people in particular. Similar to so called “food deserts,” “pharmacy deserts” means that black people especially and non-white in general have predictably less access to pharmacies than White people and fewer services offered at these sparse locations - such as 24 hour access, home delivery and in-store immunizations. We'll emphasize that White people are not ignorant about black people's poor access to pharmacies. This is what they want. And we'll highlight the data that shows even poor White people have better medical services than black people. #ItsNotClass #TheCOWS14Years INVEST in The COWS – http://paypal.me/TheCOWS Cash App: https://cash.app/$TheCOWS CALL IN NUMBER: 605.313.5164 CODE: 564943#

Robert Page, a professor in the Departments of Clinical Pharmacy and Physical Medicine at the University of Colorado, joins Tim to talk about some new developments in determining significant cardiovascular risks associated with marijuana use, regardless of the reason. He's the lead author on a new paper from the American Heart Association that exposes major risks. We talk about his paper, some of the myths surrounding medical marijuana usage, and what it all means. https://traffic.libsyn.com/forcedn/shapingopinion/Robert_Page_-_Weed_and_Heart_Health_auphonic.mp3 If I were to use a term with you, a propaganda term, do you think you'd fall for it?  Let's give it a shot. So, here's the term. What do you think of when I say, “medical marijuana?” Now, before we go any further, I need to give you a quick history lesson on the field where I work. I work in public relations. The founding fathers of this field actually called it the practice of propaganda back in those early days. And they weren't wrong. Some 100 years ago, propagandists sold everything from war bonds to cigarettes, from oil and gasoline to railroad travel. And when something went wrong, they became spin doctors. They played with the truth, and it wasn't always ethical. Since then, the field has done much to improve its own image by establishing ethical standards, but this doesn't mean that “spin” has just faded away. The battle over the truth is never-ending. If you can believe this, back in the 1930s and 40s, the advertising and public relations fields convinced Americans that smoking cigarettes was actually good for their health. At that time, the medical community had not yet discovered the link between smoking and lung cancer or lung disease. In fact, most doctors smoked cigarettes. Of course, there was evidence all around them that lung cancer was on the rise, but no one blamed cigarettes at first. Some tobacco companies even used doctors in their ads. American Tobacco was the maker of Lucky Strike cigarettes. In 1930, the company created an ad that said, “20,679 Physicians say ‘LUCKIES are less irritating'” to the throat of a smoker. To arrive at this conclusion, American Tobacco's advertising agency sent cartons of Lucky Strike cigarettes to doctors along with a letter. That letter asked those doctors whether they believed Lucky Strike cigarettes were “less irritating to sensitive and tender throats than other cigarettes.” To make sure they got the results they wanted, the letter that “a good many people” had already said Lucky Strikes were less irritating. In the end, millions of Americans came to believe that cigarettes have a medicinal effect. By 1937, the Philip Morris weighed in with an ad in the Saturday Evening Post. Keep in mind, that magazine was extremely dominant and powerful in influencing public opinion throughout the United States at the time. The Philip Morris ad said the company did a study that showed “when smokers changed to Philip Morris, every case of irritation cleared completely and definitely improved.”  The ad never mentioned the business relationship the company had with those doctors. For years, tobacco companies made claims in their advertising and marketing that smoking cigarettes are healthy, and if not good for you, the ads certainly never hinted that cigarettes could be bad for you. The R.J. Reynolds Tobacco Company even created a Medical Relations Division and promoted it through medical journals. That company paid for its own research to demonstrate the medicinal benefits of cigarette smoking. In 1946, R.J. Reynolds created a new ad campaign under the slogan, “More doctors smoke Camels than any other cigarette.” We talk to someone who knows a lot more than I do on this. Robert Page is the lead author on a new scientific paper called: “Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement from the American Heart Association.”

Leaders from CareFirst, CareSource, UPMC Health Plan and Scene Health explore how proper medication adherence ensures a higher quality of life, improves health outcomes and reduces healthcare costs. Many health plans saw their overall Medicare Star Ratings drop this year due to one particular area – medication adherence. Our expert panel from top-rated plans shares innovative and actionable strategies for overcoming barriers to medication adherence.    Topics for discussion include: Reasons traditional approaches to medication adherence are not effective Best ways to speed up intervention with a personalized, member-centric approach Financial and ratings impacts of medication adherence measures   Confirmed Panelists Tom Manetti, Associate Vice President, Quality Products, CareSource Molly McGraw, PharmD, BCPS, Manager, Clinical Pharmacy, UPMC Health Plan Suzanne Moxham, Director, Quality, Accreditation, & Government Programs at CareFirst BlueCross BlueShield Sebastian Seiguer, CEO & Co-Founder, Scene Health   Bios: https://www.brightspotsinhealthcare.com/events/how-medication-adherence-can-be-much-more-than-medication-adherence/   Connect with us on social media: Facebook: facebook.com/brightspotshc Instagram: https://www.instagram.com/brightspotshc/https://www.instagram.com/brightspotshc/ LinkedIn: https://www.linkedin.com/company/shared-purpose-connect/ Twitter: https://twitter.com/BrightSpotsinHChttps://twitter.com/BrightSpotsinHC TikTok: https://www.tiktok.com/@brightspotshchttps://www.tiktok.com/@brightspotshc This episode is sponsored by Scene Health  Meet Scene Health, the medication engagement company that's taking on the colossal $500 billion problem of medication nonadherence. But here's the twist – they're doing it in a novel way by leveraging asynchronous video engagement.   Scene's model of care enhances the CDC-endorsed gold standard for ensuring medication adherence, Directly Observed Therapy. Their team of pharmacists, nurses, and health coaches engage with members via back-and-forth videos to build trust through person-to-person connections and empower every patient to take every dose of medication properly.   And they're not just all talk. Scene Health has been clinically validated in 20 peer-reviewed publications and is already teaming up with Medicaid and Medicare health plans, public health departments, and life science organizations to tackle a range of conditions, from diabetes & asthma to sickle cell disease.

Get full access to Brownstone Insights at brownstone.substack.com/subscribe

Pharmacies in California make about 5 million errors every year, according to state regulators. That's just an estimate, since pharmacies aren't required to report mistakes, and the big chains are fighting to keep them secret. Meanwhile, pharmacists say they are overworked and underpaid, with many leaving the profession. We'll hear about a new Los Angeles Times report on pharmacy errors, talk with pharmacists about burnout, and find out what patients can do to protect themselves. Guests: Christopher Atkins, pharmacist, an independent pharmacy in LA; former pharmacist, CVS and Vons Richard Dang, assistant professor of Clinical Pharmacy, USC; immediate past president, California Pharmacists Association Melody Petersen, investigative reporter covering healthcare and business, Los Angeles Times - Petersen's latest piece is titled "California Pharmacies Are Making Millions of Mistakes. They're Fighting to Keep that Secret"

This podcast will discuss the impact that specialty pharmacy has made on their health system and how pharmacy is practiced, focusing on the how different groups utilize ambulatory and specialty pharmacy teams to meet the needs of our patients and our providers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

To claim CE credit for this activity, please follow this link: www.pharmacytimes.org/atopic-derm-podcast-630 Pharmacy Times Continuing Education™ (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-system pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multispecialty  education. Educational Objectives Review patient barriers that impact optimal treatment of patients with atopic dermatitis (AD) who are seeking OTC care List strategies to individualize patient care and improve recommendations for AD Moderator: Mary Bridgeman, PharmD, BCPS, BCGP Clinical Professor Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey Piscataway, New Jersey   Internal Medicine Clinical Pharmacist Robert Wood Johnson University Hospital New Brunswick, New Jersey   Faculty & Caregiver: Ashley Ellis, PharmD, MBA, CDECS ImPAcT Director & Assistant Professor The University of Tennessee Health Science Center Department of Clinical Pharmacy and Translation Science College of Pharmacy Memphis, Tennessee   Mary Bridgeman, PharmD, BCPS, BCGP, has no financial relationships with commercial interests to disclose. Ashley Ellis, PharmD, MBA, CDECS, has the following financial relationships with commercial interests to disclose: Grant/Research Support: Researcher AHRQ “Tennessee Heart Health Network” funding in form of salary release dollars Consultant: Global Parents for Eczema Research, Continuing Education Alliance, McGraw Hill   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity numbers 0290-0000-23-268-H01-P and 0290-0000-23-268-H01-T. The activity is available for CE credit through June 30, 2024. This activity is supported by an educational grant from CeraVe and La Roche-Posay. Brought to you in partnership with the National Eczema Association.